Drugs
Conditions
News and resources
MIMS Supported ResourcesMHRA issues suicide risk reminder for quinolones
The Medicines and Healthcare products Regulatory Agency (MHRA) has reminded prescribers to be alert to the risk of psychiatric reactions when prescribing fluoroquinolone antibiotics.
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.